Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,150 | 90,077 | 60,801 | 95,368 | 5,852 |
| Marketable Securities | 35,624 | 28,279 | 42,225 | 41,800 | 0 |
| Receivables | 209,535 | 74,770 | 58,835 | 48,578 | 38,028 |
| Inventories | 144,615 | 54,673 | 41,783 | 40,510 | 36,093 |
| Other current assets | 32,133 | 15,986 | 12,501 | 10,209 | 9,121 |
| TOTAL | $537,057 | $263,785 | $216,145 | $236,465 | $89,094 |
| Non-Current Assets | |||||
| PPE Net | 253,768 | 113,249 | 81,771 | 51,857 | 36,703 |
| Investments And Advances | 67,988 | 19,470 | 8,375 | 0 | 0 |
| Other Non-Current Assets | 216,460 | 35,337 | 16,887 | 10,804 | 11,579 |
| TOTAL | $538,216 | $168,056 | $107,033 | $62,661 | $48,282 |
| Total Assets | $1,075,273 | $431,841 | $323,178 | $299,126 | $137,376 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 34,249 | 29,456 | 20,008 | 3,792 |
| Accounts payable and accrued liabilities | 42,240 | 15,109 | 10,689 | 6,463 | 6,761 |
| Accrued Expenses | 141,030 | 14,843 | 16,894 | 10,872 | 15,139 |
| Other current liabilities | 13,625 | 3,879 | 0 | 0 | 0 |
| TOTAL | $270,481 | $73,681 | $57,074 | $42,581 | $25,692 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,162 | 0 | 0 | 0 | 17,211 |
| Other Non-Current Liabilities | 39,058 | 3,021 | 10,938 | 0 | 0 |
| TOTAL | $52,260 | $18,151 | $19,360 | $7,479 | $21,391 |
| Total Liabilities | $322,741 | $91,832 | $76,434 | $50,060 | $47,083 |
| Shareholders' Equity | |||||
| Common Shares | 1,757 | 1,018 | 1,018 | 1,018 | 942 |
| Retained earnings | 455,545 | 253,953 | 174,626 | 105,200 | 68,514 |
| Other shareholders' equity | -8,685 | -112 | -1,155 | -274 | 602 |
| TOTAL | $752,532 | $340,009 | $246,744 | $249,066 | $90,293 |
| Total Liabilities And Equity | $1,075,273 | $431,841 | $323,178 | $299,126 | $137,376 |